Keyphrases
Epidermal Growth Factor Receptor
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Brain Metastases
100%
Erlotinib
100%
Pulsatile
100%
Leptomeningeal Metastasis
100%
Cerebrospinal Fluid
28%
Central Nervous System
28%
Tyrosine Kinase Inhibitor
28%
Nervous System Diseases
28%
Therapeutic Concentrations
28%
Clinical Outcomes
14%
Response Rate
14%
High Dose
14%
Clinical Criteria
14%
Daily Dose
14%
CNS Metastases
14%
Pharmacology
14%
Resistance mutations
14%
Dose Administration
14%
T790M
14%
Medicine and Dentistry
Lung Cancer
100%
Epidermal Growth Factor Receptor
100%
Brain Metastasis
100%
Erlotinib
100%
Cerebrospinal Fluid
28%
Central Nervous System
28%
Central Nervous System Disease
28%
Tyrosine-Kinase Inhibitor
28%
Metastatic Carcinoma
14%
Drug Megadose
14%
Central Nervous System Metastasis
14%
Resistance Mutation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Lung Cancer
100%
Brain Metastasis
100%
Erlotinib
100%
Protein Tyrosine Kinase Inhibitor
28%
Central Nervous System Disease
28%
Central Nervous System Metastasis
14%